M
Maccura Biotechnology Co Ltd
SZSE:300463
Maccura Biotechnology Co Ltd
SZSE:300463
Price:
13.31 CNY
-0.3%
Updated:
May 15, 2024
EV/S
Enterprise Value to Sales
Enterprise Value to Sales
2.6
Current
2.9
Median
3.9
Industry
Lower
than median
Lower
than industry value
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
EV/S
=2.6
Enterprise Value
/
7.4B
Revenue
2.8B
All Countries
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| CN |
M
|
Maccura Biotechnology Co Ltd
SZSE:300463
|
8.1B CNY | 2.6 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
230B USD | 5.9 | |
| US |
|
Danaher Corp
NYSE:DHR
|
192B USD | 4.6 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
44.3B USD | 6.7 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
42B USD | 3.6 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
55.6T KRW | 14.8 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.6B CHF | 5.6 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
32B USD | 8.9 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
26.1B USD | 3.5 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
25.9B USD | 8.7 | |
| US |
|
Waters Corp
NYSE:WAT
|
21.3B USD | 7.9 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/S
2.3
2-Years Forward
EV/S
2
3-Years Forward
EV/S
N/A
You don't have any saved screeners yet
